Wall Street Journal (press release) Rigosertib is also being evaluated in a Phase 3 trial for first-line treatment in combination with gemcitabine for patients with metastatic pancreatic cancer who had not previously received any chemotherapy. The oral form of rigosertib is currently ... and more »
Wall Street Journal (press release) The physician's choice agents will include: ixabepilone, vinorelbine, gemcitabine , eribulin, or a taxane. The primary endpoint of the BEACON study is overall survival, and secondary endpoints include progression-free survival and objective tumor ... and more »
Business Wire (press release) Consistent with LUX-Lung 3, afatinib* treatment led to significant and sustained tumour shrinkage compared to chemotherapy ( gemcitabine / cisplatin) in LUX-Lung 6. Specifically, in approximately two thirds of patients (66.9%) taking afatinib*, the ... and more »
CBC.ca Extra saline in the bags containing cyclophosphamide and gemcitabine effectively watered down the prescribed drug concentrations by up to 20 per cent. Some of t...
Lifescience-online In April 2013, the European Medicines Agency (EMA) has also accepted for review a Type II Variation to the current Marketing Authorization Application (MAA) for ABRAXANE, in combination with gemcitabine , for the first-line treatment of patients with ...
GlobeNewswire (press release) This trial compared clivatuzumab alone to the combination of clivatuzumab with low-dose gemcitabine in an open-label, randomized trial. About Immunomedics. Immunomedics is a New Jersey-based biopharmaceutical company primarily focused on the ...
Proactive Investors USA & Canada In April, Silence started dosing of pancreatic cancer patients with the chemotherapy agent gemcitabine in combination with its lead product Atu027 and will follow this up with other chemotherapy agents in a variety of tumour types. Silence said it will ... and more »
Marketwire (press release) Nexavar in combination with gemcitabine /cisplatin is not recommended in patients with squamous cell lung cancer. The safety and effectiveness of Nexavar has not been established in patients with non-small cell lung cancer. Nexavar can prolong the QT ...
Phoenix Business Journal (blog) “The fact that Abraxane plus gemcitabine demonstrated an overall survival benefit, and also did so at one and two years, is a significant step forward in offering potential new hope for our patients.” Von Hoff is chief scientific officer for the cancer ...
